E1056 AMA: StartX & Nexus Events Founder Cameron Teitelman answers questions from founders: how universities with no entrepreneurial culture can mimic Stanford, building flexible & sustainable culture during COVID, scaling Nexus Events rapidly & more!

StartX & Nexus Events Founder Cameron Teitelman answers questions from founders: how universities with no entrepreneurial culture can mimic Stanford, building flexible & sustainable culture during COVID, scaling Nexus Events rapidly & more!

Join the TWiST Slack: https://launchevents.typeform.com/to/kLq5Bi

Mentioned during the AMA:

Cameron's new startup: https://mixer.nexusevents.io/login_mixer

Cameron's most recent TWiST appearance: https://youtu.be/zsNqOLs-NVI

Questions:

0:37 Cameron intros his AMA and describes his new company: Nexus Events https://mixer.nexusevents.io/login_mixer

1:31 Kevin: Are seed investors investing right now? What have StartX companies been seeing lately from early-stage investors?

2:55 James: How can universities with no entrepreneurial culture mimic the success of Stanford in creating an environment that encourages building and innovation?

4:29 James: How does the accelerator structure change for current students? What are some of the common pitfalls you have seen people make starting their company whilst finishing their degree?

7:18 Presh: Could you share more about your new startup? What are you building and why?

10:15 Ashley: How are you looking at accepting companies to StartX through the COVID lense? Which companies (in your portfolio or not) do you think are particularly well-positioned for the post COVID environment?

12:43 Jean: Regarding mentorship, in what areas do solo founders need the most help with?

14:41 Annette: Will Stanford affiliated applicants get priority over referral applicants? Would consumer startup applicants that are non-COVID related be considered during this time?

17:35 Henry: What are your thoughts in terms of building a flexible but sustainable culture?

19:26 Matt: Do you take a different approach with health tech portfolio companies and educate/manage/support them separately from the rest of the portfolio?

21:21 Laura: Given that companies don't give up equity, and there is no structured program, how do you cultivate high-level engagement with your founders/companies & mentors?

25:27 Luke: Can you talk about how the collaboration between StartX and the Stanford Hospital and Clinics works? How are the grants assessed and awarded?

26:14 Jacqui: Do you see the StartX Med COVID-19 Task Force as a new model to accelerate advances in biotech or to generate solutions for other critical global issues?

27:07 Heidi: How can other med schools around the country partner with you to develop satellite programs?

29:17 Dan: Do you have any war stories about running Nexus Events during COVID and what you’ve learned from it?